Delivery Order SPE2DB20D3101-SPE2DB22FK4R2
Award Date 7/25/22
Potential Completion Date 7/26/22
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $2,411.52, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication LINZESS 290 MCG CAPSULE UU 30S, with a period of performance through November 30, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a separate $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $2,918.33, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LINZESS 72 MCG Capsule, a pharmaceutical product, with a completion date of May 15, 2023. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide LINZESS 290 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $1,484.48. The ultimate completion date is July 29, 2024. This appears to be a contract under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 that Amerisourcebergen holds with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,758.28 firm fixed-price delivery order is for the pharmaceutical product LINZESS 145 MCG CAPSULE UU 30S. The contract has a period of performance through February 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of LINZESS 290 MCG CAPSULE, a pharmaceutical product, with a ceiling value of $2,771.32 and a completion date of February 13, 2024. The contract was awarded on February 12, 2024 as a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $1,615.02 with a Firm Fixed Price pricing type and an ultimate completion date of October 16, 2023. The contract is for the pharmaceutical product LINZESS 145 MCG CAPSULE UU 30S. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL81T, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product LINZESS 72 MCG CAPSULE UU 30S, with a ceiling value of $10,457.45. This is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has a ceiling value of $5,366.63 and is a firm fixed price, non-set-aside contract with a period of performance through July 7, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a larger Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication LINZESS 145 MCG CAPSULE UU 30S. The contract has a ceiling value of $2,567.16 and a period of performance through April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a medication, with a ceiling value of $2,915.98. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 and running through November 2026. This IDC serves as a...